Home | Services & Solutions | Drug Product | Oral | Solid State Development

solid state dev and material science img Solid State Development

Solid-state properties for oral solid drugs can significantly impact their pharmaceutical performance. A thorough characterization of solid-state behavior of the API and drug product is critical to the success of the drug development at all stages.

Our experts in solid state chemistry, powder characterization, and material science are dedicated to accelerating your drug substance and drug product development from preclinical to commercial manufacturing. With a team of dedicated scientists, we conduct 400+ solid form screening projects and 60,000+ various characterization tests at all development stages every year.  We also support high potency compound with OEL of 10ng/m3.

scientist icon


Characterization icon

Characterization Tests Annually

lab-space icon
1,000+ m2

Lab Space

projects icon

Projects Annually

advanced instruments icon


Support Entire New Drug Development Life Cycle
for Both Drug Substance and Drug Product

Phase I
Phase II
Phase III
Solid State Chemistry

Salt/cocrystal screening and polymorph screening for tox and clinical development

Comprehensive polymorph study for NDA filing

Salt and polymorph study for technical life cycle management

Solid state characterization

Solid form quantitative analysis

Crystal structure analysis

Simulation and modeling

Trouble shooting

Powder Characterization

Flowability | Particle size | Morphology | Surface area | Density

Material Science

SEM-EDS | Micro-CT | Raman | Wettability | Texture analysis

Solid State Chemistry

Salt/cocrystal screening and polymorph screening for tox and clinical development

Solid State Characterization

Crystal Structure Analysis

Phase I
Phase II
Solid State Chemistry

Comprehensive polymorph study for NDA filing

Solid form quantitative method development

Simulation and Modeling

Phase III

Salt and Polymorph study for Technical Life Cycle Management

Solid form quantitative method development

Trouble shooting


Flowability | Particle Size | Morphology | Surface Area | Density


SEM-EDS | Micro-CT | Raman | Wettability | Texture Analysis

Various cutting-edge instruments to support general and specific testing

  • XRPD
  • VT-, VH-XRPD
  • Capillary XRPD
  • DSC/mDSC
  • TGA
  • DVS (GVS)
  • PLM with a thermal stage
  • Stereo microscope
  • Confocal Raman
  • Confocal IR
  • Ss-NMR
  • FT-IR
  • Particle size analyzer (PSD)
  • True density tester
  • Ribbon density tester
  • Tapped density tester
  • Powder flow analyzer (FT4)
  • Specific surface area
  • Texture analyzer
  • Contact angle analyzer (wettability)
  • Confocal Raman
  • XRM (micro-CT)
  • Micro-ED
image 122 Solid State Development

Pave an Expressway to Phase I – Strategies that Accelerate Your Early Phase Programs

The success of any new drug development starts in its early phase. The probability of success of a molecule increases dramatically after it passes first-in-human (FIH) and proof-of-concept (POC) studies. Building a comprehensive understanding of the molecule is crucial to successful early phase development. API salt form and formulation selections are also key factors to successful phase I studies. Effective CMC strategies can significantly enhance the speed of early phase development and ultimately the chance for success in late-stage development. This webinar will present our experience in using the integrated API and drug product platform and formulation technologies to accelerate early-phase development to phase I and beyond. Access on-demand webinars & videos In this webinar, we will discuss the importance of phase-appropriate process development and various

Watch the Webinar Now
Scroll to Top
Please enable JavaScript in your browser to complete this form.